Global Anaesthesia Vaporizer Market - 2024-2031

Global Anaesthesia Vaporizer Market - 2024-2031

The global anaesthesia vaporiser market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Anaesthesia vaporisers vaporize a liquid anaesthetic agent and deliver a controlled amount to the patient. There are three types of concentration-calibrated vaporisers variable bypass, heated blender, and electronically controlled vapor cassettes. These devices are used in operating rooms, emergency departments, delivery rooms, trauma departments, ambulatory surgical centres, and any areas requiring the administration of an inhalation agent. In the vast majority of cases, vaporizers will be mounted on anaesthesia machines; however, vaporizers can also be associated with cardiopulmonary bypass consoles by the use of special mounting blocks.

Vaporizers are an important part of anaesthesia equipment. An understanding of physiology and physics is warranted to ensure the adequate use of these devices. The timely recognition of problems in vaporizer functioning is also essential, as this will decrease the amount of time that patients are potentially exposed to light anaesthesia and pain.

Market Dynamics: Drivers

Rise in Technological Advancements

The demand for the anaesthesia vaporizer market is driven by multiple factors. The rise in the advancements in anaesthesia vaporizer technology, such as precision dosing and safety features, attracts healthcare providers to upgrade their equipment. Many advancements have been released where it helps the market to grow during the forecast period. For example, The Drager DIVA vaporiser which is integrated into the Zeus anaesthesia machine allows for target-controlled anaesthesia with closed-loop quantitative control of the delivery of oxygen, carrier gas and anaesthetic vapour.

Furthermore, factors such as an increase in the number of surgeries, a rise in several hospitals and clinics, growth in the geriatric population, and high healthcare expenditure drive the market growth. The increase in demand for the anaesthesia vaporizer masks market in emerging nations and R&D in the field of surgical equipment is anticipated to create new opportunities during the forecast period.

Moreover, major players in the industry introduce technological innovations that would drive this market. For instance, in August 2023, Mindray launched modifications for the A7 and A5 anaesthesia devices in support of its A-Series anaesthesia. The most recent enhancements feature novel innovations which enable anesthesiologists to deliver accurate anaesthesia, leading to improved consumer health and effectiveness during the time after surgery.

Restraints

Factors such as product recalls, the high cost of the devices, legal and financial consequences for the manufacturers, and complexity in the regulatory requirements are expected to hamper the market.

Segment Analysis

The anaesthesia vaporizer market is segmented based on product type, agent-specific, end-user, and region.

The plenum vaporizers segment accounted for approximately 54.4% of the anaesthesia vaporizer market share

The plenum vaporizers segment is expected to hold the largest market share over the forecast period. The plenum vaporizer is driven by positive pressure from the anaesthetic machine and is usually mounted on the machine. The performance of the vaporizer does not change regardless of whether the patient is breathing spontaneously or is mechanically ventilated.

As per a research publication in NCBI in January 2023, plenum vaporizers are characterized by a pressurized vaporization chamber that generates an increased internal resistance (above atmospheric pressure) for fresh gas flow. This type of vaporizer is currently the most commonly used and is characterized by its accuracy in the mixture of gases provided to the patient.

Moreover, it is not temperature-compensated. When the control knob, which is just a crude split ratio controller, is in the down position, the cowling over the U-tube descends and brings the FGF closer to the surface of the agent or forces it to bubble through the ether, increasing output by increasing the gas/liquid interface.

According to the Scholarly Community Encyclopedia review in November 2022, plenum vaporizer is a typical volatile agent, isoflurane, and has a saturated vapour pressure of 32kPa (about 1/3 of an atmosphere). This means that the gas mixture leaving the vaporising chamber has a partial pressure of isoflurane of 32kPa. At sea level (atmospheric pressure is about 101kPa), this equates conveniently to a concentration of 32%. However, the output of the vaporizer is typically set at 1–2%, which means that only a very small proportion of the fresh gas needs to be diverted through the vaporising chamber.

Furthermore, the industry's major player's product approvals drive this market. For instance, in April 2022, GE Healthcare stated that the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anaesthesia delivery on its Aisys CS2 Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anaesthesia delivery with end-tidal concentration control in the U.S. The company initially released the technology in Europe in 2010 and anesthesia providers use Et Control software to care for patients in over 100 countries.

Geographical Analysis

North America accounted for approximately 41.2% of the anaesthesia vaporizer market share

North America region is expected to hold the largest market share over the forecast period owing to the strategic partnerships with key players, improved healthcare infrastructure, product launches by key players and others that will help this region to grow during the forecast period.

In this region, key players' presence strategies such as partnerships and collaborations and well-organized healthcare infrastructure help to propel this market. For instance, in March 2023, North American Partners in Anaesthesia (NAPA) would expand in Texas with the announcement of our newest partnership with Methodist Hospital, Metropolitan, part of Methodist Healthcare, to deliver anaesthesia services.

NAPA will employ 16 professionals to deliver anaesthesia treatment at Methodist Hospital Metropolitan in San Antonio, Texas, adopting a Physician/CRNA care team approach. The 378-bed hospital includes 12 surgery suites, 16 NICU beds, and an additional women's section.

COVID-19 Impact Analysis

Covid 19 had a substantial impact on the global anaesthesia vaporizer market and the COVID-19 pandemic has led to an increased demand for healthcare services, including surgeries and medical procedures, which has boosted the performance of the healthcare sector.

Also, during the pandemic over 20% of coronavirus victims suffered from acute respiratory distress syndrome needing lifesaving therapies in ICUs which led to enormous resource and infrastructure challenges. However, the crisis arguably created the perfect incubator for new ideas and accelerated innovation in anaesthesia vaporizers which helped the market to grow during the forecast period.

Market Segmentation

By Product Type
• Plenum Vaporizers
• Drawover Vaporizers
• Tec3 Vaporizers

By Agent Specific
• Single Agent
• Multiple Agent

By End-Users
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the anaesthesia vaporizer market include GE Healthcare, Medline, Nanjing Chenwei Medical Equipment Co., Ltd., Dolphinmed, Conduct Science, Penlon, Drägerwerk AG & Co. KGaA, iClearhealthcare, Harvard Apparatus and MellMed among others.

Key Developments

 On April 30, 2024, Medline announced that it had entered into a definitive agreement to acquire the global surgical solutions business of Ecolab, Inc., including the industry-leading Microtek product lines. Once closed, the acquisition will provide Medline with innovative sterile drape solutions for surgeons, patients, and operating room equipment, as well as Ecolab’s fluid temperature management system.

 On April 7, 2023, National Partners in Healthcare (""NPH""), a national healthcare organization delivering best-in-class anesthesiology services and a portfolio company of Assured Healthcare Partners, announced that Medstream Anesthesia Solutions (""Medstream"") has joined NPH. Texas Capital Bank agented and arranged a $125,000,000 senior secured debt facility to support the acquisition, refinance existing debt and provide growth capital to NPH.

Why Purchase the Report??
• To visualize the anaesthesia vaporizer market segmentation based on product type, agent-specific, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of anaesthesia vaporizer market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.

The anaesthesia vaporizer market report would provide approximately 62 tables, 54 figures, and 181 Pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies